The metabolic responses induced by acute dexamethasone predict glucose tolerance and insulin secretion over 10years in relatives of type 2 diabetic subjects
The metabolic responses induced by acute dexamethasone predict glucose tolerance and insulin secretion over 10years in relatives of type 2 diabetic subjects
复制标题
DOI:
10.1002/dmrr.2418
复制
发表时间:
2013-09-01
影响因子:
8
通讯作者:
Alford, Frank P.
中科院分区:
文献类型:
--
作者:
Durck, Tina Trier;Henriksen, Jan Erik;Alford, Frank P.
Background This study aimed to compare the metabolic and insulin secretory responses to dexamethasone with the metabolic responses observed at 10years in normoglycaemic relatives of type 2 diabetic and healthy control subjects.Methods Twenty relatives and 20 matched control subjects were studied twice at 0year (pre- and post-dexamethasone) and at 10years, employing a 75-g oral glucose tolerance test (OGTT), with serial measurements of glucose and insulin, for determination of glucose tolerance and calculations of acute insulin release (I-30/G(30); insulinogenic index) and insulin sensitivity (SIHOMA).Results Following dexamethasone, the relatives group developed varying degrees of glucose intolerance, associated with reduced insulin sensitivity and insulinogenic index. By 10years, fasting glucose and 2-h OGTT glucose were raised in the relatives group, especially in the relatives most metabolically affected by dexamethasone, including a reduced insulinogenic index. Multiple regression analysis of the data in relatives demonstrated that the 2-h OGTT glucose and fasting glucose values at 10years depended on the 0-year post-dexamethasone 2-h OGTT glucose, post-dexamethasone fasting glucose and post-dexamethasone insulin sensitivity, r(adj)(2)=56% (p